He reports that he has been not drinking very frequently because he is in a detox program but he was nervous this week after seeing Dr [**Last Name (STitle) 724**] regarding a brain tumor that was identified on his last admission.
He was persistently tachycardic and hypertensive and required valium 5mg x 3, ativan 2mg x 2, and metoprolol 50mg PO x 1.
He also received a MVI/thiamine 100mg/folic acid 1mg.
Past Medical History: -- HTN -- CAD s/p RCA stent in [**8-/2164**] -- s/p closed fract tib/fib -- SVT (AVRT v. AVNRT) -- Chronic EtOH abuse (no h/o seizures; s/p detox 3 years ago, referred to [**Hospital1 1680**] house partial hospitalization program [**5-5**]) -- Depression/anxiety ([**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 66064**] [**Numeric Identifier 100681**] @ [**Hospital1 1680**] JP; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 12528**] [**Telephone/Fax (1) 5260**]) -- Neurofibromatosis - dx on last admission  Social History: Unemployed, living alone in [**Location (un) **] MA.
Physical Exam: T 97.2 BP 138/117 HR 121 RR19 O2 95%RA General: comfortable, lying in bed, appears slightly dissheveled HEENT: PERRL, poor dentition Neck: soft, NT/ND Cardiac: tachycardic Pulmonary: CTA B/L Abdomen: soft non-tender, non-distended, + bowel sounds Extremities: no edema, mild tremor of the hands Skin: numerous small subcutaneous nodules  Pertinent Results: None  Brief Hospital Course: The patient is a 58M h/o SVT, CAD s/p stent, chronic EtOH abuse, depression and anxiety presenting with EtOH intoxication.
He was nervous about an upcoming MRI and drank heavily on the day of admission.
He was placed on valium TID and PRN based on CIWA scale.
He received MVI/thiamine and folic acid daily.
During his hospital course he did not require any CIWA coverage and did not show any signs of withdrawl.
His HR was in the 130s in ED, but was well controlled in the ICU after being placed back on his home dose beta blocker (metoprolol 50 TID).
He was discharged on atenolol 100mg daily.
# Neurofibromatosis: The patient was diagnosed with neurofibromatosis on his last admission earlier this month.
Medications on Admission: ASA 81 mg [**Last Name (un) **] Celexa 20 mg qday Atenolol Lisinopril  Discharge Medications: 1.
Hexavitamin     Tablet Sig: One (1) Cap PO DAILY (Daily).
Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Atenolol 100 mg Tablet Sig: One (1) Tablet PO once a day: Please take one pill daily.
Disp:*30 Tablet(s)* Refills:*1*   Discharge Disposition: Home  Discharge Diagnosis: Primary Diagnosis: ETOH intoxication ETOH withdrawl  Secondary Diagnosis: Chronic EtOH abuse HTN CAD s/p RCA stent in [**8-/2164**] s/p closed fract tib/fib SVT (AVRT v. AVNRT) Depression/anxiety Neurofibromatosis  Discharge Condition: Stable - Patient was ambulating, tolerating oral intake, and has returned to his baseline condition.
It will be important for you to abstain from further alcohol use and continue your program at [**Hospital1 1680**] House.
When you were in the hospital, we also increased your heart rate medication to atenolol 100mg daily.
